Background. In recent years, growing evidence has highlighted the crucial role of genetic testing in the diagnosis, treatment, and management of patients affected by cardiovascular diseases, particularly cardiomyopathies. However, there is significant variability in the clinical and molecular presentation of these diseases, along with regional heterogeneity in genetic background…